13F HOLDINGS REPORT
Darwin Global Management, Ltd.
Quarter ended Q1 2023 · Filed February 14, 2023 · Accession 0001892688-23-000024
Total Value
$160.6M
Positions
4
Other Managers
0
Confidential Omitted
No
Holdings (4)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ARGENX SE | ARGX | 297,701 | $112.8M | 70.21% |
| 2 | KEROS THERAPEUTICS INC | KROS | 428,532 | $20.6M | 12.81% |
| 3 | AMBRX BIOPHARMA INC | 02290A102 | 7,584,489 | $17.2M | 10.72% |
| 4 | PROMETHEUS BIOSCIENCES INC | 74349U108 | 91,379 | $10.1M | 6.26% |